AAAAAA

   
Results: 1-24 |
Results: 24
INTERFERON ALPHA-2A THERAPY CAUSES INSULIN-DEPENDENT DIABETES-MELLITUS AS AN ORGANSPECIFIC REVERSIBLE AUTOIMMUNE-DISEASE IN CHRONIC HEPATITIS-C
Authors: GATZEN M PAUSCH J MANFRAS BJ WIEST U LOLIGER C KUHNL P VANENDERT P BOEHM BO
Citation: M. Gatzen et al., INTERFERON ALPHA-2A THERAPY CAUSES INSULIN-DEPENDENT DIABETES-MELLITUS AS AN ORGANSPECIFIC REVERSIBLE AUTOIMMUNE-DISEASE IN CHRONIC HEPATITIS-C, Hepatology, 28(4), 1998, pp. 2125-2125
SCHEDULE-DEPENDENCY OF 10-MU-G KG G-CSF IN STEADY-STATE MOBILIZATION OF CD34+ PROGENITOR CELLS IN HIGH-RISK BREAST-CANCER PATIENTS (PTS)/
Authors: KROGER N ZELLER W HASSAN T KRUGER W HUMMEL K LOLIGER C BIERMAN B KUHNL P ZANDER AR
Citation: N. Kroger et al., SCHEDULE-DEPENDENCY OF 10-MU-G KG G-CSF IN STEADY-STATE MOBILIZATION OF CD34+ PROGENITOR CELLS IN HIGH-RISK BREAST-CANCER PATIENTS (PTS)/, Bone marrow transplantation, 21, 1998, pp. 810-810
THE IMPACT OF HLA ON LONG-TERM OUTCOME AFTER THYMECTOMY FOR MYASTHENIA-GRAVIS
Authors: MACHENS A LOLIGER C PICHLMEIER U EMSKOTTER T BUSCH C IZBICKI JR
Citation: A. Machens et al., THE IMPACT OF HLA ON LONG-TERM OUTCOME AFTER THYMECTOMY FOR MYASTHENIA-GRAVIS, Journal of neuroimmunology, 88(1-2), 1998, pp. 177-181
INSULIN-DEPENDENT DIABETES-MELLITUS DUE TO INTERFERON ALPHA-2A THERAPY FOR CHRONIC VIRAL-HEPATITIS-C
Authors: GATZEN CM MANFRAS BJ WIEST U RICHTER W LOLIGER C KUHNL P VANENDERT P PAUSCH J BOEHM BO
Citation: Cm. Gatzen et al., INSULIN-DEPENDENT DIABETES-MELLITUS DUE TO INTERFERON ALPHA-2A THERAPY FOR CHRONIC VIRAL-HEPATITIS-C, Gastroenterology, 114(4), 1998, pp. 192-192
SCHEDULE-DEPENDENCY OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN BREAST-CANCER PATIENTS
Authors: KROGER N ZELLER W HASSAN HT KRUGER W LOLIGER C ZANDER AR
Citation: N. Kroger et al., SCHEDULE-DEPENDENCY OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN BREAST-CANCER PATIENTS, Blood, 91(5), 1998, pp. 1828-1828
ALLOGENEIC TRANSPLANTATION WITH CD34(-SELECTED CELLS())
Authors: STOCKSCHLADER M HASSAN HT ZELLER W KRUGER W CLAUSEN J LOLIGER C DIECK AT KROGER N LINK H KABISCH H HOSSFELD DK ZANDER A
Citation: M. Stockschlader et al., ALLOGENEIC TRANSPLANTATION WITH CD34(-SELECTED CELLS()), Leukemia & lymphoma, 25(1-2), 1997, pp. 145-151
GERMAN CONSENSUS ON IMMUNOGENETIC DONOR SEARCH FOR TRANSPLANTATION OFALLOGENEIC BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELLS
Authors: OTTINGER HD ALBERT E ARNOLD R BEELEN DW BLASCZYK R BUNJES D BURDACH S EBELL W EHNINGER G EINSELE H ENCZMANN J FAUSER A FRIEDRICH W FINKE J GOBEL U GOLDMANN SF GRAMATZKI M HELBIG W KANZ L KLINGSBIEL T KOLB HJ KUHNL P LOLIGER C MULLER CR MULLER CA NIETHAMMER D SCHAEFER UW SAYER H SCHMITZ N SCHULZERATH R WASSMUTH R WERNET P WESTPHAL E ZANDER R ZINTL F GROSSEWILDE H
Citation: Hd. Ottinger et al., GERMAN CONSENSUS ON IMMUNOGENETIC DONOR SEARCH FOR TRANSPLANTATION OFALLOGENEIC BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELLS, Bone marrow transplantation, 20(2), 1997, pp. 101-105
LONG-TERM FOLLOW-UP OF LEUKEMIA PATIENTS AFTER RELATED CRYOPRESERVED ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: STOCKSCHLADER M HASSAN HT KROG C KRUGER W LOLIGER C HORSTMAN M ALTNODER M CLAUSEN J GRIMM J KABISCH H ZANDER A
Citation: M. Stockschlader et al., LONG-TERM FOLLOW-UP OF LEUKEMIA PATIENTS AFTER RELATED CRYOPRESERVED ALLOGENEIC BONE-MARROW TRANSPLANTATION, British Journal of Haematology, 96(2), 1997, pp. 382-386
ANTIPLATELET ANTIBODIES (AB) IN THIOPURINE THERAPY OF CHILDHOOD ACUTELYMPHOBLASTIC-LEUKEMIA (ALL)
Authors: JANKA GE HARMS D RAUSCHE T LOLIGER C
Citation: Ge. Janka et al., ANTIPLATELET ANTIBODIES (AB) IN THIOPURINE THERAPY OF CHILDHOOD ACUTELYMPHOBLASTIC-LEUKEMIA (ALL), Blood, 90(10), 1997, pp. 3830-3830
SUCCESSFUL TREATMENT OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, HLH, WITHUNRELATED AND RELATED ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: DURKEN M HORSTMANN M BIELING P KABISCH H ERTTMANN R LOLIGER C KRUGER W KROGER N JANKA G ZANDER A
Citation: M. Durken et al., SUCCESSFUL TREATMENT OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, HLH, WITHUNRELATED AND RELATED ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 90(10), 1997, pp. 4525-4525
10 MU-G VERSUS 2 X 5 MU-G G-CSF IN STEADY-STATE MOBILIZATION OF CD34(-RISK BREAST-CANCER PATIENTS (PTS) - HIGHER YIELD BY SPLITTING THE DOSE() PROGENITOR CELLS IN HIGH)
Authors: KROGER N ZELLER W HASSAN T KRUGER W HUMMEL K GOEPFERT C LOLIGER C BIERMANN B ZANDER AR
Citation: N. Kroger et al., 10 MU-G VERSUS 2 X 5 MU-G G-CSF IN STEADY-STATE MOBILIZATION OF CD34(-RISK BREAST-CANCER PATIENTS (PTS) - HIGHER YIELD BY SPLITTING THE DOSE() PROGENITOR CELLS IN HIGH), Blood, 90(10), 1997, pp. 2630-2630
PURGING AND PROGENITOR SELECTION BY CD34-SEPARATION - A COMPARISON OF3 DEVICES()
Authors: KRUGER WH GRUBER M STOCKSCHLADER M HENNINGS S FEHSE N SCHLEIMER B HASSAN HT GUTENSOHN K LOLIGER C ZANDER AR
Citation: Wh. Kruger et al., PURGING AND PROGENITOR SELECTION BY CD34-SEPARATION - A COMPARISON OF3 DEVICES(), Experimental hematology, 24(9), 1996, pp. 603-603
ATG AS PART OF THE PRETRANSPLANT CONDITIONING REGIMEN REDUCES TRANSPLANT-RELATED MORTALITY IN CML PATIENTS UNDERGOING ALLOGENEIC BMT
Authors: STOCKSCHLADER M KRUGER W BETKER R LOLIGER C DEWIT M HORSTMANN M KROGER N ERTTMANN R ZANDER R
Citation: M. Stockschlader et al., ATG AS PART OF THE PRETRANSPLANT CONDITIONING REGIMEN REDUCES TRANSPLANT-RELATED MORTALITY IN CML PATIENTS UNDERGOING ALLOGENEIC BMT, Experimental hematology, 24(9), 1996, pp. 679-679
USE OF CRYOPRESERVED BONE-MARROW IN UNRELATED ALLOGENEIC TRANSPLANTATION
Authors: STOCKSCHLADER M KRUGER W DIECK AT HORSTMANN M ALTNODER M LOLIGER C FIEDLER W HOFFKNECHT M ERTTMANN R ZANDER A
Citation: M. Stockschlader et al., USE OF CRYOPRESERVED BONE-MARROW IN UNRELATED ALLOGENEIC TRANSPLANTATION, Bone marrow transplantation, 17(2), 1996, pp. 197-199
CYTOKERATIN-19 REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION AND CELL-CULTURE DETECTION OF CANCER-CELLS IN G-CSF-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS OF WOMEN WITH BREAST-CANCER
Authors: KRUGER WH HENNINGS S ASCHENBRENNER M GRUBER M STOCKSCHLADER M GUTENSOHN K LOLIGER C GIESEKING F JONAT W ZANDER AR
Citation: Wh. Kruger et al., CYTOKERATIN-19 REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION AND CELL-CULTURE DETECTION OF CANCER-CELLS IN G-CSF-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS OF WOMEN WITH BREAST-CANCER, Blood, 88(10), 1996, pp. 999-999
LONG-TERM REMISSION OF CHRONIC MYELOGENOUS LEUKEMIA FOLLOWING ALLOGENEIC TRANSPLANTATION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN THE 4TH CHRONIC PHASE AFTER FAILING PREVIOUS BONE-MARROW TRANSPLANTATION AND DONOR LEUKOCYTE TRANSFUSION
Authors: STOCKSCHLADER M HASSAN HT LOLIGER C ZANDER AR
Citation: M. Stockschlader et al., LONG-TERM REMISSION OF CHRONIC MYELOGENOUS LEUKEMIA FOLLOWING ALLOGENEIC TRANSPLANTATION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN THE 4TH CHRONIC PHASE AFTER FAILING PREVIOUS BONE-MARROW TRANSPLANTATION AND DONOR LEUKOCYTE TRANSFUSION, Acta haematologica, 96(4), 1996, pp. 262-263
PREFERENTIAL EXPRESSION OF T-CELL RECEPTOR V-BETA-CHAINS IN ATOPIC ECZEMA
Authors: NEUBER K LOLIGER C KOHLER I RING J
Citation: K. Neuber et al., PREFERENTIAL EXPRESSION OF T-CELL RECEPTOR V-BETA-CHAINS IN ATOPIC ECZEMA, Acta dermato-venereologica, 76(3), 1996, pp. 214-218
PRETRANSPLANT CYTOTOXIC T-CELL PRECURSOR FREQUENCIES CORRELATE WITH TRANSPLANT-RELATED MORTALITY AFTER UNRELATED BMT
Authors: SPEISER DE RUFER N GRATWOHL A CHAPUIS B HELG C LOLIGER C SIREN MK ROOSNEK E JEANNET M
Citation: De. Speiser et al., PRETRANSPLANT CYTOTOXIC T-CELL PRECURSOR FREQUENCIES CORRELATE WITH TRANSPLANT-RELATED MORTALITY AFTER UNRELATED BMT, Experimental hematology, 23(8), 1995, pp. 866-866
IN-VITRO STIMULATION WITH GLUTAMIC-ACID DECARBOXYLASE (GAD65) LEADS TO AN OLIGOCLONAL RESPONSE OF PERIPHERAL T-CELLS IN AN IDDM PATIENT
Authors: WEISS U MANFRAS BJ TERJUNG D EIERMANN T WOLPL A LOLIGER C KUHNL P BOEHM BO
Citation: U. Weiss et al., IN-VITRO STIMULATION WITH GLUTAMIC-ACID DECARBOXYLASE (GAD65) LEADS TO AN OLIGOCLONAL RESPONSE OF PERIPHERAL T-CELLS IN AN IDDM PATIENT, Scandinavian journal of immunology, 42(6), 1995, pp. 673-678
TRANSPLANTATION OF ALLOGENEIC RHG-CSF MOBILIZED PERIPHERAL CD34(-IDENTICAL UNRELATED DONOR() CELLS FROM AN HLA)
Authors: STOCKSCHLADER M LOLIGER C KRUGER W ZELLER W HEYLL A SCHONROCKNABULSI P ZANDER A
Citation: M. Stockschlader et al., TRANSPLANTATION OF ALLOGENEIC RHG-CSF MOBILIZED PERIPHERAL CD34(-IDENTICAL UNRELATED DONOR() CELLS FROM AN HLA), Bone marrow transplantation, 16(5), 1995, pp. 719-722
USE OF CRYOPRESERVED BONE-MARROW IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: STOCKSCHLADER M KRUGER W KROSCHKE G ZELLER W HOFFKNECHT M LOLIGER C KABISCH H ZANDER A
Citation: M. Stockschlader et al., USE OF CRYOPRESERVED BONE-MARROW IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(4), 1995, pp. 569-572
UNSEPARATED CD34(+)-ENRICHED, ALLOGENEIC/SYNGENEIC, RELATED/UNRELATEDPERIPHERAL STEM-CELL TRANSPLANTATIONS/INFUSIONS ALONE OR IN COMBINATION WITH ALLOGENEIC BMT IN 15 PATIENTS - A SINGLE-CENTER EXPERIENCE/
Authors: STOCKSCHLADER M ZELLER W KRUGER W CLAUSEN J DIECK AT LOLIGER C HOFFKNECHT M ZANDER A
Citation: M. Stockschlader et al., UNSEPARATED CD34(+)-ENRICHED, ALLOGENEIC/SYNGENEIC, RELATED/UNRELATEDPERIPHERAL STEM-CELL TRANSPLANTATIONS/INFUSIONS ALONE OR IN COMBINATION WITH ALLOGENEIC BMT IN 15 PATIENTS - A SINGLE-CENTER EXPERIENCE/, Blood, 86(10), 1995, pp. 419-419
BLOOD-TRANSFUSION RELATED INFECTION RISK
Authors: KUHNL P LOLIGER C LAUFS R
Citation: P. Kuhnl et al., BLOOD-TRANSFUSION RELATED INFECTION RISK, Chirurg, 65(12), 1994, pp. 1071-1074
HISTOCOMPATIBILITY ANTIGENS IN VITILIGO - HAMBURG STUDY ON 102 PATIENTS FROM NORTHERN GERMANY
Authors: SCHALLREUTER KU LEVENIG C KUHNL P LOLIGER C HOHLTEHARI M BERGER J
Citation: Ku. Schallreuter et al., HISTOCOMPATIBILITY ANTIGENS IN VITILIGO - HAMBURG STUDY ON 102 PATIENTS FROM NORTHERN GERMANY, Dermatology, 187(3), 1993, pp. 186-192
Risultati: 1-24 |